Sweden · Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 23.36 billion. The enterprise value is 21.50 billion.
| Market Cap | 23.36B |
| Enterprise Value | 21.50B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.64 million shares outstanding. The number of shares has increased by 0.74% in one year.
| Current Share Class | 74.24M |
| Shares Outstanding | 88.64M |
| Shares Change (YoY) | +0.74% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 30.81% |
| Owned by Institutions (%) | 47.69% |
| Float | 55.57M |
Valuation Ratios
The trailing PE ratio is 21.94 and the forward PE ratio is 32.58.
| PE Ratio | 21.94 |
| Forward PE | 32.58 |
| PS Ratio | 12.56 |
| PB Ratio | 11.48 |
| P/TBV Ratio | 11.48 |
| P/FCF Ratio | 22.80 |
| P/OCF Ratio | 22.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.35, with an EV/FCF ratio of 20.98.
| EV / Earnings | 20.15 |
| EV / Sales | 11.56 |
| EV / EBITDA | 16.35 |
| EV / EBIT | 16.78 |
| EV / FCF | 20.98 |
Financial Position
The company has a current ratio of 8.63, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.63 |
| Quick Ratio | 7.40 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 43.08 |
Financial Efficiency
Return on equity (ROE) is 71.96% and return on invested capital (ROIC) is 52.09%.
| Return on Equity (ROE) | 71.96% |
| Return on Assets (ROA) | 46.25% |
| Return on Invested Capital (ROIC) | 52.09% |
| Return on Capital Employed (ROCE) | 61.86% |
| Revenue Per Employee | 15.63M |
| Profits Per Employee | 8.97M |
| Employee Count | 107 |
| Asset Turnover | 1.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 106.92 million in taxes.
| Income Tax | 106.92M |
| Effective Tax Rate | 9.11% |
Stock Price Statistics
The stock price has increased by +81.99% in the last 52 weeks. The beta is -0.92, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.92 |
| 52-Week Price Change | +81.99% |
| 50-Day Moving Average | 292.49 |
| 200-Day Moving Average | 226.07 |
| Relative Strength Index (RSI) | 34.99 |
| Average Volume (20 Days) | 107,660 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 1.86 billion and earned 1.07 billion in profits. Earnings per share was 12.01.
| Revenue | 1.86B |
| Gross Profit | 1.81B |
| Operating Income | 1.28B |
| Pretax Income | 1.17B |
| Net Income | 1.07B |
| EBITDA | 1.30B |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | 12.01 |
Balance Sheet
The company has 1.92 billion in cash and 48.99 million in debt, giving a net cash position of 1.87 billion or 21.07 per share.
| Cash & Cash Equivalents | 1.92B |
| Total Debt | 48.99M |
| Net Cash | 1.87B |
| Net Cash Per Share | 21.07 |
| Equity (Book Value) | 2.04B |
| Book Value Per Share | 23.00 |
| Working Capital | 1.98B |
Cash Flow
In the last 12 months, operating cash flow was 1.05 billion and capital expenditures -26.64 million, giving a free cash flow of 1.02 billion.
| Operating Cash Flow | 1.05B |
| Capital Expenditures | -26.64M |
| Free Cash Flow | 1.02B |
| FCF Per Share | 11.56 |
Margins
Gross margin is 97.21%, with operating and profit margins of 68.88% and 57.37%.
| Gross Margin | 97.21% |
| Operating Margin | 68.88% |
| Pretax Margin | 63.12% |
| Profit Margin | 57.37% |
| EBITDA Margin | 69.99% |
| EBIT Margin | 68.88% |
| FCF Margin | 55.10% |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.74% |
| Shareholder Yield | -0.74% |
| Earnings Yield | 4.57% |
| FCF Yield | 4.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |